Edwards Lifesciences Corporation Payments to Acquire Available-for-sale Securities
Edwards Lifesciences Corporation (EW) reported Payments to Acquire Available-for-sale Securities of $0 for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-04-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireAvailableForSaleSecurities · last filed 2018-04-27
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for the quarter ending 2017-12-31 was $52.00M, a 61.02% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for the quarter ending 2017-09-30 was $145.50M, a 10.30% decline year-over-year.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for the quarter ending 2017-06-30 was $164.90M, a 62.62% increase year-over-year.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for fiscal 2017 was $529.80M, a 12.63% increase from fiscal 2016.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for fiscal 2016 was $470.40M, a 23.69% increase from fiscal 2015.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for fiscal 2015 was $380.30M, a 137.09% increase from fiscal 2014.
- Edwards Lifesciences Corporation payments to acquire available-for-sale securities for fiscal 2014 was $160.40M.
| Period end | Payments to Acquire Available-for-sale Securities 3 month | Payments to Acquire Available-for-sale Securities 6 month | Payments to Acquire Available-for-sale Securities 9 month | Payments to Acquire Available-for-sale Securities 12 month |
|---|---|---|---|---|
| 2018-03-31 | $0.00 10-Q · filed 2018-04-27 | $52.00M derived: sum of 2 quarters · filed 2018-04-27 | $197.50M derived: sum of 3 quarters · filed 2018-04-27 | $362.40M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-12-31 | $52.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $197.50M derived: sum of 2 quarters · filed 2018-02-16 | $362.40M derived: sum of 3 quarters · filed 2018-02-16 | $529.80M 10-K · filed 2018-02-16 |
| 2017-09-30 | $145.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $310.40M derived: sum of 2 quarters · filed 2017-10-27 | $477.80M 10-Q · filed 2017-10-27 | $611.20M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-06-30 | $164.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $332.30M 10-Q · filed 2017-07-28 | $465.70M derived: sum of 3 quarters · filed 2018-04-27 | $627.90M derived: sum of 4 quarters · filed 2018-04-27 |
| 2017-03-31 | $167.40M 10-Q · filed 2018-04-27 | $300.80M derived: sum of 2 quarters · filed 2018-04-27 | $463.00M derived: sum of 3 quarters · filed 2018-04-27 | $564.40M derived: sum of 4 quarters · filed 2018-04-27 |
| 2016-12-31 | $133.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $295.60M derived: sum of 2 quarters · filed 2018-02-16 | $397.00M derived: sum of 3 quarters · filed 2018-02-16 | $470.40M 10-K · filed 2018-02-16 |
| 2016-09-30 | $162.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | $263.60M derived: sum of 2 quarters · filed 2017-10-27 | $337.00M 10-Q · filed 2017-10-27 | $410.10M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $101.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | $174.80M 10-Q · filed 2017-07-28 | $247.90M derived: sum of 3 quarters · filed 2018-02-16 | $348.50M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $73.40M 10-Q · filed 2017-04-28 | $146.50M derived: sum of 2 quarters · filed 2018-02-16 | $247.10M derived: sum of 3 quarters · filed 2018-02-16 | $369.10M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $73.10M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $173.70M derived: sum of 2 quarters · filed 2018-02-16 | $295.70M derived: sum of 3 quarters · filed 2018-02-16 | $380.30M 10-K · filed 2018-02-16 |
| 2015-09-30 | $100.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $222.60M derived: sum of 2 quarters · filed 2016-10-28 | $307.20M 10-Q · filed 2016-10-28 | $467.60M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $122.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $206.60M 10-Q · filed 2016-07-29 | $367.00M derived: sum of 3 quarters · filed 2017-02-17 | $367.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $84.60M 10-Q · filed 2016-04-29 | $245.00M derived: sum of 2 quarters · filed 2017-02-17 | $245.00M derived: sum of 3 quarters · filed 2017-02-17 | $245.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $160.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $160.40M derived: sum of 2 quarters · filed 2017-02-17 | $160.40M derived: sum of 3 quarters · filed 2017-02-17 | $160.40M 10-K · filed 2017-02-17 |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | $0.00 derived: sum of 2 quarters · filed 2015-10-29 | $0.00 10-Q · filed 2015-10-29 | |
| 2014-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | $0.00 10-Q · filed 2015-07-29 | ||
| 2014-03-31 | $0.00 10-Q · filed 2015-04-29 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |